In a first in Indian athletics, Paul, a 400m hurdler and 400m relay runner, was banned by the Anti-Doping Disciplinary Panel of the NADA for possessing Meldonium.
"I am going to file an appeal to the Anti-Doping Appeal Panel very soon. We have got 21 days from the date of the order," Paul told PTI.
The banned drug was recovered from Paul's room during a surprise raid on the hostel premises of a few athletes and coaches at NIS Patiala on April 17 last year.
"NADA has framed me by fabricating a case. Only Carnitine injection was recovered from my room and I have admitted it. This Mnaapohat (chemical formula of Meldonium) was never recovered from my room. I only came to know about this (Mnaapohat) on May 22 when I was served a provisional supsension," he said.
Paul's counsel Parth Goswami termed the decision of the Anti-Doping Disciplinary Panel "shocking" and said his client has been denied "natural justice". Goswami said Paul was not given the seizure memo when the raid took place in April last year.
"How will an athlete have a record in his possession about which substance was recovered from him? The NADA official ought to have provided it there and then at the time of seizure. This is natural justice and my client has been denied natural justice."
Goswami said instead of giving a seizure memo, Paul was told to sign on an envelope.
Paul said that he signed on that envelope after writing that Carnitine injection was found from his room.
"When I signed the envelope, there was only Carnitine injection written on it and not
Mnaapohat. There were also cuttings on the envelopes which shows that this injection Mnaapohat was squeezed in to fit in above my signature."
NADA's submission, included in the final order of the Anti-Doping Disciplinary Panel, simply said that, "the sealed envelope was prepared on the spot and the signature of the athlete was also taken upon the same". NADA submitted that its officer sealed the envelope in the presence of the athlete.
The NADA submitted that the numerical writing/over-writing on the envelope was a clerical error and the same was corrected in front of the athlete. The Anti-Doping Panel accepted NADA's submission, saying that the "clerical error does not have an effect on the labaratory analysis results, that is Meldonium".
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
